Unnikrishnan, A., Deshpande, N., Verma, A., Kumari, A., Richards, L., Knezevic, K., . . . Pimanda, J. (2017). Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes. Cell Press.
Chicago-Zitierstil (17. Ausg.)Unnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
MLA-Zitierstil (9. Ausg.)Unnikrishnan, A., et al. Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes. Cell Press, 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.